Edward W Frykman - Net Worth and Insider Trading

Edward W Frykman Net Worth

The estimated net worth of Edward W Frykman is at least $361,886 dollars as of 2024-05-06. Edward W Frykman is the Director of Acacia Research Corp and owns about 45,757 shares of Acacia Research Corp (ACTG) stock worth over $237,936. Edward W Frykman is also the Director of Arrowhead Pharmaceuticals Inc and owns about 5,000 shares of Arrowhead Pharmaceuticals Inc (ARWR) stock worth over $123,950. Details can be seen in Edward W Frykman's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Edward W Frykman has not made any transactions after 2010-12-08 and currently still holds the listed stock(s).

Transaction Summary of Edward W Frykman

To

Edward W Frykman Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Edward W Frykman owns 2 companies in total, including Arrowhead Pharmaceuticals Inc (ARWR) , and Acacia Research Corp (ACTG) .

Click here to see the complete history of Edward W Frykman’s form 4 insider trades.

Insider Ownership Summary of Edward W Frykman

Ticker Comapny Transaction Date Type of Owner
ARWR Arrowhead Pharmaceuticals Inc 2004-01-30 director
ACTG Acacia Research Corp 2010-12-08 director

Edward W Frykman Latest Holdings Summary

Edward W Frykman currently owns a total of 2 stocks. Among these stocks, Edward W Frykman owns 45,757 shares of Acacia Research Corp (ACTG) as of December 8, 2010, with a value of $237,936 and a weighting of 65.75%. Edward W Frykman also owns 5,000 shares of Arrowhead Pharmaceuticals Inc (ARWR) as of January 30, 2004, with a value of $123,950 and a weighting of 34.25%.

Latest Holdings of Edward W Frykman

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ACTG Acacia Research Corp 2010-12-08 45,757 5.20 237,936
ARWR Arrowhead Pharmaceuticals Inc 2004-01-30 5,000 24.79 123,950

Holding Weightings of Edward W Frykman


Edward W Frykman Form 4 Trading Tracker

According to the SEC Form 4 filings, Edward W Frykman has made a total of 0 transactions in Acacia Research Corp (ACTG) over the past 5 years. The most-recent trade in Acacia Research Corp is the sale of 27,400 shares on December 8, 2010, which brought Edward W Frykman around $801,998.

According to the SEC Form 4 filings, Edward W Frykman has made a total of 0 transactions in Arrowhead Pharmaceuticals Inc (ARWR) over the past 5 years. The most-recent trade in Arrowhead Pharmaceuticals Inc is the sale of 0 shares on January 30, 2004, which brought Edward W Frykman around $0.

Insider Trading History of Edward W Frykman

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Edward W Frykman Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Edward W Frykman Ownership Network

Ownership Network List of Edward W Frykman

No Data

Ownership Network Relation of Edward W Frykman


Edward W Frykman Owned Company Details

What does Arrowhead Pharmaceuticals Inc do?

Who are the key executives at Arrowhead Pharmaceuticals Inc?

Edward W Frykman is the director of Arrowhead Pharmaceuticals Inc. Other key executives at Arrowhead Pharmaceuticals Inc include other: Senior Vice President James C Hamilton , CFO Kenneth Allen Myszkowski , and director & President and CEO Christopher Richard Anzalone .

Arrowhead Pharmaceuticals Inc (ARWR) Insider Trades Summary

Over the past 18 months, Edward W Frykman made no insider transaction in Arrowhead Pharmaceuticals Inc (ARWR). Other recent insider transactions involving Arrowhead Pharmaceuticals Inc (ARWR) include a net sale of 266,472 shares made by Christopher Richard Anzalone , a net sale of 79,524 shares made by James C Hamilton , and a net sale of 101,729 shares made by Kenneth Allen Myszkowski .

In summary, during the past 3 months, insiders sold 46,000 shares of Arrowhead Pharmaceuticals Inc (ARWR) in total and bought 3,000 shares, with a net sale of 43,000 shares. During the past 18 months, 608,104 shares of Arrowhead Pharmaceuticals Inc (ARWR) were sold and 3,000 shares were bought by its insiders, resulting in a net sale of 605,104 shares.

Arrowhead Pharmaceuticals Inc (ARWR)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Arrowhead Pharmaceuticals Inc Insider Transactions

No Available Data

Edward W Frykman Mailing Address

Above is the net worth, insider trading, and ownership report for Edward W Frykman. You might contact Edward W Frykman via mailing address: 1 Wilshire Blvd, Los Angeles Ca 90017.

Discussions on Edward W Frykman

No discussions yet.